Literature DB >> 19653080

Performance in population models for count data, part I: maximum likelihood approximations.

Elodie L Plan1, Alan Maloney, Iñaki F Trocóniz, Mats O Karlsson.   

Abstract

There has been little evaluation of maximum likelihood approximation methods for non-linear mixed effects modelling of count data. The aim of this study was to explore the estimation accuracy of population parameters from six count models, using two different methods and programs. Simulations of 100 data sets were performed in NONMEM for each probability distribution with parameter values derived from a real case study on 551 epileptic patients. Models investigated were: Poisson (PS), Poisson with Markov elements (PMAK), Poisson with a mixture distribution for individual observations (PMIX), Zero Inflated Poisson (ZIP), Generalized Poisson (GP) and Negative Binomial (NB). Estimations of simulated datasets were completed with Laplacian approximation (LAPLACE) in NONMEM and LAPLACE/Gaussian Quadrature (GQ) in SAS. With LAPLACE, the average absolute value of the bias (AVB) in all models was 1.02% for fixed effects, and ranged 0.32-8.24% for the estimation of the random effect of the mean count (lambda). The random effect of the overdispersion parameter present in ZIP, GP and NB was underestimated (-25.87, -15.73 and -21.93% of relative bias, respectively). Analysis with GQ 9 points resulted in an improvement in these parameters (3.80% average AVB). Methods implemented in SAS had a lower fraction of successful minimizations, and GQ 9 points was considerably slower than 1 point. Simulations showed that parameter estimates, even when biased, resulted in data that were only marginally different from data simulated from the true model. Thus all methods investigated appear to provide useful results for the investigated count data models.

Entities:  

Mesh:

Year:  2009        PMID: 19653080     DOI: 10.1007/s10928-009-9126-8

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  17 in total

Review 1.  Simulation of clinical trials.

Authors:  N H Holford; H C Kimko; J P Monteleone; C C Peck
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  Estimating bias in population parameters for some models for repeated measures ordinal data using NONMEM and NLMIXED.

Authors:  Siv Jönsson; Maria C Kjellsson; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-08       Impact factor: 2.745

3.  Derivation of various NONMEM estimation methods.

Authors:  Yaning Wang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-07-10       Impact factor: 2.745

4.  Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1983-06

5.  Experience with NONMEM: analysis of routine phenytoin clinical pharmacokinetic data.

Authors:  L B Sheiner; T H Grasela
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

6.  Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

7.  Evaluation of mixture modeling with count data using NONMEM.

Authors:  Bill Frame; Raymond Miller; Richard L Lalonde
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-06       Impact factor: 2.745

8.  Modelling overdispersion and Markovian features in count data.

Authors:  Iñaki F Trocóniz; Elodie L Plan; Raymond Miller; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-10-02       Impact factor: 2.745

9.  Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1980-12

10.  A demonstration of modeling count data with an application to physical activity.

Authors:  Donald J Slymen; Guadalupe X Ayala; Elva M Arredondo; John P Elder
Journal:  Epidemiol Perspect Innov       Date:  2006-03-21
View more
  15 in total

1.  Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.

Authors:  Elodie L Plan; Alan Maloney; France Mentré; Mats O Karlsson; Julie Bertrand
Journal:  AAPS J       Date:  2012-04-14       Impact factor: 4.009

2.  Implementation and evaluation of the SAEM algorithm for longitudinal ordered categorical data with an illustration in pharmacokinetics-pharmacodynamics.

Authors:  Radojka M Savic; France Mentré; Marc Lavielle
Journal:  AAPS J       Date:  2010-11-11       Impact factor: 4.009

3.  Performance in population models for count data, part II: a new SAEM algorithm.

Authors:  Radojka Savic; Marc Lavielle
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-08-13       Impact factor: 2.745

4.  Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-06-10       Impact factor: 2.745

5.  Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models.

Authors:  Jurgen B Bulitta; Cornelia B Landersdorfer
Journal:  AAPS J       Date:  2011-03-04       Impact factor: 4.009

6.  D optimal designs for three Poisson dose-response models.

Authors:  Alan Maloney; Ulrika S H Simonsson; Marloes Schaddelee
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-19       Impact factor: 2.745

7.  Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7.

Authors:  Åsa M Johansson; Sebastian Ueckert; Elodie L Plan; Andrew C Hooker; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-05-07       Impact factor: 2.745

8.  Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep model.

Authors:  C Steven Ernest; Joakim Nyberg; Mats O Karlsson; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-12       Impact factor: 2.745

9.  A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.

Authors:  A Gulati; F Bagnato; P Villoslada; N Velez de Mendizabal
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-04-24

10.  A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration-Resistant Prostate Cancer.

Authors:  M Wilbaux; M Tod; J De Bono; D Lorente; J Mateo; G Freyer; B You; E Hénin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.